Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine vs Bupivacaine for Supraclavicular Block in Upper Limb Surgery
NCT04189198Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of articaine in pain (2 arms), sponsored by Ain Shams University. Primary endpoints: Duration of sensory block at 24 hours, Duration of motor block at 24 hours and 1 more. Started Dec 2019; status: completed.
02
Drugs
articaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04189198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189198.